Skip to content

Effects of IMT on Respiratory, Diaphragmatic and Balance Functions, Exercise Capacity and QOL in People After Stroke

Effects of Inspiratory Muscle Training on Respiratory and Diaphragmatic Functions, Balance Control, Exercise Capacity and Quality of Life in People After Stroke: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06447272
Enrollment
76
Registered
2024-06-07
Start date
2025-04-01
Completion date
2026-06-01
Last updated
2025-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Inspiratory muscle training, Diaphragm, Balance control, Exercise capacity

Brief summary

This is a randomized controlled trial. This current RCT study will be a continuing project based on the optimal IMT intensity identified from our ongoing study. This ongoing study (registered on ClinicalTrials.gov with the registration number NCT06267768) aims to explore the optimal IMT intensity for the recruitment of diaphragm muscles in people after a stroke. Based on this intensity, the aim of this RCT is to explore the effects of a 4-week protocol of IMT on respiratory function, balance control, exercise capacity, and quality of life in people after a stroke.

Interventions

This group will receive conventional treatment + sham IMT (with 10% MIP as the training intensity)

OTHERtarget inspiratory muscle training

This group will receive conventional treatment + target IMT (the IMT identified as optimal intensity based on the results of our undergoing study).

Sponsors

Hong Kong Metropolitan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* aged between 40 and 80 years; * breathing spontaneously; * clinically diagnosed with ischemic and/or haemorrhagic stroke; * stroke duration from onset between 1 and 12 months; * no history of thoracic or abdominal surgery within the last 6 months; * able to understand and follow verbal instructions; * no facial palsy, or mild facial palsy without limitation of labial occlusion; * capable of maintaining a resting sitting posture without feet support for at least 30 seconds; * no cognitive impairment, as indicated by a Montreal Cognitive Assessment (MoCA) score of ≥ 26; * able to independently walk at least 10 meters with or without an assistive device.

Exclusion criteria

* acute myocardial infarction or acute heart failure; * acute pain in any part of the body; * with respiratory illness or positive clinical signs of impaired respiratory function, such as shortness of breath, hypoxemia, chronic cough, or sputum retention; * with chronic cardiovascular dysfunction; * Trunk Impairment Scale (TIS) score ≥ 20; * presence of a nasal feeding tube, tracheal tube, or any condition that prevents the measurement or implementation of the study procedure.

Design outcomes

Primary

MeasureTime frameDescription
Diaphragmatic thicknessbaseline, after 4 weeks of interventionThe diaphragmatic thickness of both the left and right diaphragms will be measured by ultrasound. (Mindray M9, Shenzhen, China).

Secondary

MeasureTime frameDescription
Forced Expiratory Volume in one second (FEV1)baseline, after 4 weeks of interventionForced Expiratory Volume in one second (FEV1) measures the volume of air a person can forcibly exhale in the first second of a forced breath. It will be measured using the spirometer.
Maximum Inspiratory Pressure (MIP)baseline, after 4 weeks of interventionMaximum Inspiratory Pressure (MIP) is a measure used in pulmonary function testing to assess the strength of the respiratory muscles, particularly the muscles used for inhalation. It will be measured using the spirometer.
Trunk Impairment Scale (TIS)baseline, after 4 weeks of interventionThe TIS is a rating scale used to measure static sitting balance, dynamic sitting balance, and trunk coordination. The total TIS score ranges from 0 to 23 points, with a higher score indicating better trunk function.
Sitting Balancebaseline, after 4 weeks of interventionA force plate will be used to measure changes in the center of pressure during the performance of various tasks in sitting positions.
Forced Vital Capacity (FVC)baseline, after 4 weeks of interventionForced Vital Capacity (FVC) is a measurement used in pulmonary function tests to assess lung function. It refers to the total volume of air that a person can forcibly exhale from their lungs after taking the deepest breath possible. It will be measured using the spirometer.
Falls efficacy scale internationalbaseline, after 4 weeks of intervention, 12-week follow-up after the end of interventionThe Falls Efficacy Scale-International (FES-I) is a questionnaire measuring fear of falling in older adults. It consists of 16 items, each scored from 1 to 4, with higher scores indicating greater fear. The total score ranges from 16 (lowest fear) to 64 (highest fear). It is used in clinical settings to assess fall risk and tailor interventions.
6-Minute Walk Testbaseline, after 4 weeks of interventionThe 6-Minute Walk Test (6MWT) measures how far someone can walk in six minutes. It assesses exercise capacity and mobility.
Stroke Impact Scalebaseline, after 4 weeks of intervention, 12-week follow-up after the end of interventionThe Chinese version of the Stroke Impact Scale 3.0 (SIS) will be used to measure the quality of life. Scores range from 0 to 100, a higher overall score suggests better physical, emotional, and social functioning, while a lower score may indicate more significant impairment or limitations.
Timed Up and Go Test (TUG)baseline, after 4 weeks of interventionTUG is a test to measure the time that a participant needs to stand up from a standard armchair, walk a short distance of about 3 meters, turn around, walk back to the chair, and sit down again.

Contacts

Primary ContactFang LIU
s1350035@live.hkmu.edu.hk+8613603049475
Backup ContactWilliam Wai Nam Tsang
wntsang@hkmu.edu.hk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026